About MRD

Keeping an eye on your child’s cancer is an essential part of treating it

clonoSEQ is a test that helps your child’s doctor keep an eye on their MRD status throughout treatment

  • Understand your child’s cancer and make a treatment plan1
  • Assess how the amount of cancer in their body is changing over time2
  • Uncover information other tests
    may miss2,3,6-8
  • Measure their response to treatment, and potentially adjust their treatment plan to improve the outcome4
  • Detect the return of cancer before physical signs and symptoms arise2,9,10

The insights gained from clonoSEQ MRD testing can support shared decision-making throughout your child’s care


of doctors said they would change at least one decision based on their patient’s MRD status—even if all other factors remained the same11*

*In an MRD testing awareness survey.

Here are some questions to help you start a conversation with your child’s doctor.

  • What is MRD?
  • How will measuring MRD inform decisions related to my child’s cancer treatment?
  • At what points during my child’s treatment plan might they need MRD testing?
  • What might a positive or negative MRD result mean for my child?


  1. clonoSEQ®. [technical summary]. Seattle, WA. Adaptive Biotechnologies; 2020.
  2. Pulsipher M, et al. Blood. 2015;125(22):3501-3508.
  3. Wood B, et al. Blood. 2018;131(12):1350-1359.
  4. Perrot A, et al. Blood. 2018;132(23):2456-2464
  5. Thompson P, et al. Blood. 2019;134(22):1951-1959.
  6. Short N, et al. Blood Adv. 2022;6(13):4006-4014.
  1. Pulsipher M, et al. Blood Cancer Discov. 2022;3(1):66-81.
  2. Avet-Loiseau H, et al. Blood. 2015;126(23):191.
  3. Logan A, et al. Biol Blood Marrow Transplant. 2014;20(9):1307-1313.
  4. Roschewski M, et al. Lancet Oncol. 2015;16(5):541-549.
  5. Derman B, et al. Blood Cancer J. 2022;12:108.